Mushroom supplement tested against smoking damage
NCT ID NCT07316400
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 25 times
Summary
This study tested whether a daily capsule of polysaccharide peptide (PsP) from the reishi mushroom could lower markers of oxidative stress and inflammation in 200 adults who smoke or are around smoke. Participants took either PsP or a placebo for 8 weeks, and researchers measured changes in blood levels of key substances related to cell damage and inflammation. The goal was to gather knowledge about how this supplement might affect the body's response to smoke exposure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Brawijaya
Malang, East Java, 65145, Indonesia
Conditions
Explore the condition pages connected to this study.